Insulinoma staging: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 57: | Line 57: | ||
| style="font-weight: bold;" | M1 | | style="font-weight: bold;" | M1 | ||
| Distant metastasis | | Distant metastasis | ||
|} | |||
===Anatomic Stage/Prognostic Groups=== | |||
{| class="wikitable" | |||
! style="font-weight: bold;" | Stage | |||
! style="font-weight: bold;" | T | |||
! style="font-weight: bold;" | N | |||
! style="font-weight: bold;" | M | |||
|- | |||
| style="font-weight: bold;" | 0 | |||
| Tis | |||
| N0 | |||
| M0 | |||
|- | |||
| style="font-weight: bold;" | IA | |||
| T1 | |||
| N0 | |||
| M0 | |||
|- | |||
| style="font-weight: bold;" | IB | |||
| T2 | |||
| N0 | |||
| M0 | |||
|- | |||
| style="font-weight: bold;" | IIA | |||
| T3 | |||
| N0 | |||
| M0 | |||
|- | |||
| rowspan="3" style="font-weight: bold;" | IIB | |||
| T1 | |||
| N1 | |||
| M0 | |||
|- | |||
| T2 | |||
| N1 | |||
| M0 | |||
|- | |||
| T3 | |||
| N1 | |||
| M0 | |||
|- | |||
| style="font-weight: bold;" | III | |||
| T4 | |||
| Any N | |||
| M0 | |||
|- | |||
| style="font-weight: bold;" | IV | |||
| Any T | |||
| Any N | |||
| M1 | |||
|} | |} | ||
Revision as of 16:08, 2 October 2015
Insulinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Insulinoma staging On the Web |
American Roentgen Ray Society Images of Insulinoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
According to The American Joint Committee on Cancer (AJCC), there are four stages of insulinoma based on the TNM staging sysytem.
Staging
According to The American Joint Committee on Cancer (AJCC), there are four stages of insulinoma based on the TNM staging sysytem:[1]
TNM Classification
T | Primary Tumor |
---|---|
Tx | Primary tumor cannot be assessed |
T0 | No evidence of primary tumor |
Tis | Carcinoma in situ |
T1 | Tumor limited to the pancreas, ≤2 cm in greatest dimension |
T2 | Tumor limited to the pancreas, >2 cm in greatest dimension |
T3 | Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery |
T4 | Tumor involves the celiac axis or the superior mesenteric artery (unresectable primary tumor) |
N | Regional Lymph Nodes |
---|---|
NX | Regional lymph nodes cannot be assessed |
N0 | No regional lymph node metastasis |
N1 | Regional lymph node metastasis |
M | Distant Metastases |
---|---|
M0 | No distant metastasis |
M1 | Distant metastasis |
Anatomic Stage/Prognostic Groups
Stage | T | N | M |
---|---|---|---|
0 | Tis | N0 | M0 |
IA | T1 | N0 | M0 |
IB | T2 | N0 | M0 |
IIA | T3 | N0 | M0 |
IIB | T1 | N1 | M0 |
T2 | N1 | M0 | |
T3 | N1 | M0 | |
III | T4 | Any N | M0 |
IV | Any T | Any N | M1 |
References
- ↑ Stage Information for Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_199